163 related articles for article (PubMed ID: 37209783)
1. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
[TBL] [Abstract][Full Text] [Related]
2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
3. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
[TBL] [Abstract][Full Text] [Related]
4. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
[No Abstract] [Full Text] [Related]
5. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
Arita Y; Shigeta K; Akita H; Suzuki T; Kufukihara R; Kwee TC; Ishii R; Mikami S; Okuda S; Kikuchi E; Oya M; Jinzaki M
Eur Radiol; 2021 Feb; 31(2):875-883. PubMed ID: 32829418
[TBL] [Abstract][Full Text] [Related]
7. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
[TBL] [Abstract][Full Text] [Related]
8. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
Carando R; Afferi L; Marra G; Krajewski W; Pagliarulo V; Abufaraj M; Xylinas E; Cathelineau X; Sanchez-Salas R; Moschini M
Arab J Urol; 2020 Mar; 18(2):67-71. PubMed ID: 33029409
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
Ueno Y; Takeuchi M; Tamada T; Sofue K; Takahashi S; Kamishima Y; Hinata N; Harada K; Fujisawa M; Murakami T
Eur Urol; 2019 Jul; 76(1):54-56. PubMed ID: 30922688
[TBL] [Abstract][Full Text] [Related]
12. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
[TBL] [Abstract][Full Text] [Related]
13. Vesical Imaging-Reporting and Data System (VI-RADS®): Initial experience in the classification of muscle-invasive bladder cancer.
Etxano J; Rodríguez-Vigil B; Pérez F; Beardo P; Viguri A; Tolosa E; Martínez de Guereñu B
Actas Urol Esp (Engl Ed); 2021 May; 45(4):320-325. PubMed ID: 33531283
[TBL] [Abstract][Full Text] [Related]
14. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
Gmeiner J; Garstka N; Helbich TH; Shariat SF; Baltzer PA
Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
[TBL] [Abstract][Full Text] [Related]
15. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer.
Kimura K; Yoshida S; Tsuchiya J; Kitazume Y; Waseda Y; Tanaka H; Yokoyama M; Toda K; Yoshimura R; Masaya I; Koga F; Tateishi U; Fujii Y
Eur Radiol; 2023 Sep; 33(9):6245-6255. PubMed ID: 37045982
[TBL] [Abstract][Full Text] [Related]
16. Vesical imaging reporting and data system (VI-RADS) could predict the survival of bladder-cancer patients who received radical cystectomy.
Zhuang J; Cai L; Sun H; Wu Q; Li K; Yu R; Cao Q; Li P; Yang X; Lu Q
Sci Rep; 2023 Dec; 13(1):21502. PubMed ID: 38057353
[TBL] [Abstract][Full Text] [Related]
17. Visual MRI T-category versus VI-RADS evaluation from multiparametric MRI in the detection of muscle-invasion in patients with suspected bladder cancer: single centre registered clinical trial (MIB-trial).
Nikulainen I; Salminen AP; Jambor I; Merisaari H; Tammilehto V; Taimen P; Seikkula H; Boström PJ
Scand J Urol; 2021 Oct; 55(5):354-360. PubMed ID: 34448679
[TBL] [Abstract][Full Text] [Related]
18. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Woo S; Panebianco V; Narumi Y; Del Giudice F; Muglia VF; Takeuchi M; Ghafoor S; Bochner BH; Goh AC; Hricak H; Catto JWF; Vargas HA
Eur Urol Oncol; 2020 Jun; 3(3):306-315. PubMed ID: 32199915
[TBL] [Abstract][Full Text] [Related]
20. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study.
Marchioni M; Primiceri G; Delli Pizzi A; Basilico R; Berardinelli F; Mincuzzi E; Castellucci R; Sessa B; Di Nicola M; Schips L
Clin Genitourin Cancer; 2020 Oct; 18(5):409-415.e1. PubMed ID: 32273236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
